• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用动态对比增强 CT 评估肺癌患者的肿瘤治疗反应。

Assessing Tumor Response to Treatment in Patients with Lung Cancer Using Dynamic Contrast-Enhanced CT.

机构信息

Department of Diagnostic Radiology, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark.

Department of Technology, Faculty of Health and Technology, Metropolitan University College, 2200 Copenhagen, Denmark.

出版信息

Diagnostics (Basel). 2016 Jul 21;6(3):28. doi: 10.3390/diagnostics6030028.

DOI:10.3390/diagnostics6030028
PMID:27455330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5039562/
Abstract

The aim of this study was to provide an overview of the literature available on dynamic contrast-enhanced computed tomography (DCE-CT) as a tool to evaluate treatment response in patients with lung cancer. This systematic review was compiled according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Only original research articles concerning treatment response in patients with lung cancer assessed with DCE-CT were included. To assess the validity of each study we implemented Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2). The initial search yielded 651 publications, and 16 articles were included in this study. The articles were divided into groups of treatment. In studies where patients were treated with systemic chemotherapy with or without anti-angiogenic drugs, four out of the seven studies found a significant decrease in permeability after treatment. Four out of five studies that measured blood flow post anti-angiogenic treatments found that blood flow was significantly decreased. DCE-CT may be a useful tool in assessing treatment response in patients with lung cancer. It seems that particularly permeability and blood flow are important perfusion values for predicting treatment outcome. However, the heterogeneity in scan protocols, scan parameters, and time between scans makes it difficult to compare the included studies.

摘要

本研究旨在提供关于动态对比增强计算机断层扫描(DCE-CT)作为评估肺癌患者治疗反应的工具的文献综述。本系统评价根据系统评价和荟萃分析的首选报告项目(PRISMA)指南编制。仅纳入使用 DCE-CT 评估肺癌患者治疗反应的原始研究文章。为了评估每项研究的有效性,我们实施了诊断准确性研究的质量评估(QUADAS-2)。最初的搜索产生了 651 篇出版物,其中 16 篇文章被纳入本研究。这些文章分为治疗组。在对接受系统化疗联合或不联合抗血管生成药物治疗的患者进行的研究中,7 项研究中有 4 项发现治疗后通透性显著下降。在测量抗血管生成治疗后血流的 5 项研究中,有 4 项发现血流明显减少。DCE-CT 可能是评估肺癌患者治疗反应的有用工具。似乎通透性和血流特别重要,是预测治疗结果的灌注值。然而,扫描方案、扫描参数和扫描之间的时间的异质性使得比较纳入的研究变得困难。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77a7/5039562/665e170321f3/diagnostics-06-00028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77a7/5039562/665e170321f3/diagnostics-06-00028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77a7/5039562/665e170321f3/diagnostics-06-00028-g001.jpg

相似文献

1
Assessing Tumor Response to Treatment in Patients with Lung Cancer Using Dynamic Contrast-Enhanced CT.使用动态对比增强 CT 评估肺癌患者的肿瘤治疗反应。
Diagnostics (Basel). 2016 Jul 21;6(3):28. doi: 10.3390/diagnostics6030028.
2
Dynamic Contrast-Enhanced CT in Patients with Pancreatic Cancer.动态对比增强 CT 在胰腺癌患者中的应用。
Diagnostics (Basel). 2016 Sep 6;6(3):34. doi: 10.3390/diagnostics6030034.
3
Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.动态对比增强微计算机断层扫描与三维荧光超显微镜在乳腺癌异种移植抗血管生成治疗中的相关性。
Invest Radiol. 2014 Jul;49(7):445-56. doi: 10.1097/RLI.0000000000000038.
4
Development of a dynamic flow imaging phantom for dynamic contrast-enhanced CT.动态对比增强 CT 用动态血流成像模体的研制。
Med Phys. 2011 Aug;38(8):4866-80. doi: 10.1118/1.3615058.
5
The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib.动态对比增强 CT、MRI 和 US 测量的血管反应参数在接受舒尼替尼治疗的转移性肾细胞癌患者中的预后和预测价值。
Eur Radiol. 2018 Jun;28(6):2281-2290. doi: 10.1007/s00330-017-5220-2. Epub 2018 Jan 30.
6
Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.在头颈部肿瘤的预处理FDG-PET/CT中实施动态对比增强CT以进行预后预测的初步评估。
Acta Radiol. 2010 Sep;51(7):793-9. doi: 10.3109/02841851.2010.491092.
7
Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype.开发动态对比增强计算机断层扫描(DCE-CT)以量化具有不同血管生成表型的乳腺肿瘤中的肿瘤内异质性。
IEEE Trans Med Imaging. 2009 Jun;28(6):861-71. doi: 10.1109/TMI.2008.2012035. Epub 2009 Jan 13.
8
Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.动态对比增强 CT 成像生物标志物与免疫组织化学相关,用于监测索拉非尼对实验性前列腺癌的作用。
Invest Radiol. 2012 Jan;47(1):49-57. doi: 10.1097/RLI.0b013e3182300fe4.
9
Can visual assessment of blood flow patterns by dynamic contrast-enhanced computed tomography distinguish between malignant and benign lung tumors?通过动态对比增强计算机断层扫描对血流模式进行视觉评估能否区分肺恶性肿瘤和良性肿瘤?
Acta Radiol Open. 2017 May 30;6(5):2058460117710053. doi: 10.1177/2058460117710053. eCollection 2017 May.
10
Early evaluation of targeted therapy effectiveness in non-small cell lung cancer by dynamic contrast-enhanced CT.动态对比增强 CT 对非小细胞肺癌靶向治疗效果的早期评价。
Clin Transl Oncol. 2016 Jan;18(1):47-57. doi: 10.1007/s12094-015-1335-6. Epub 2015 Aug 5.

引用本文的文献

1
Assessing the effect of scanning parameter on the size and density of pulmonary nodules: a phantom study.评估扫描参数对肺结节大小和密度的影响:一项体模研究。
BMC Med Imaging. 2024 Jan 5;24(1):12. doi: 10.1186/s12880-023-01190-4.
2
CT perfusion imaging can detect residual lung tumor early after radiofrequency ablation: a preliminary animal study on both tumoral and peri-tumoral region assessment.CT灌注成像可在射频消融术后早期检测出残留肺肿瘤:一项关于肿瘤及肿瘤周围区域评估的初步动物研究。
J Thorac Dis. 2022 Jan;14(1):64-75. doi: 10.21037/jtd-21-967.
3
Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.

本文引用的文献

1
Computed Tomography (CT) Perfusion in Abdominal Cancer: Technical Aspects.腹部癌症的计算机断层扫描 (CT) 灌注:技术方面。
Diagnostics (Basel). 2013 Apr 3;3(2):261-70. doi: 10.3390/diagnostics3020261.
2
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
3
Human Recombinant Endostatin Combined with Cisplatin Based Doublets in Treating Patients with Advanced NSCLC and Evaluation by CT Perfusion Imaging.重组人血管内皮抑素联合含顺铂双药方案治疗晚期非小细胞肺癌及CT灌注成像评估
动态对比增强超声(D-CEUS)用于预测转移性结直肠癌患者贝伐珠单抗疗效的早期评估。
Eur Radiol. 2018 Jul;28(7):2969-2978. doi: 10.1007/s00330-017-5254-5. Epub 2018 Feb 7.
4
[Quantitative Imaging Assessment of Tumor Response to Chemoradiation 
in Lung Cancer].[肺癌中肿瘤对放化疗反应的定量成像评估]
Zhongguo Fei Ai Za Zhi. 2017 Jun 20;20(6):407-414. doi: 10.3779/j.issn.1009-3419.2017.06.07.
Asian Pac J Cancer Prev. 2015;16(15):6765-8. doi: 10.7314/apjcp.2015.16.15.6765.
4
Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.非小细胞肺癌患者和肿瘤异质性的多参数成像:肿瘤缺氧、代谢和灌注的量化
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):240-248. doi: 10.1007/s00259-015-3169-4. Epub 2015 Sep 4.
5
Early evaluation of targeted therapy effectiveness in non-small cell lung cancer by dynamic contrast-enhanced CT.动态对比增强 CT 对非小细胞肺癌靶向治疗效果的早期评价。
Clin Transl Oncol. 2016 Jan;18(1):47-57. doi: 10.1007/s12094-015-1335-6. Epub 2015 Aug 5.
6
Comparative study on CT perfusion parameters of different types of lung cancer before and after chemoradiotherapy.不同类型肺癌放化疗前后CT灌注参数的对比研究
J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):675-81.
7
Value of whole-tumor dual-input perfusion CT in predicting the effect of multiarterial infusion chemotherapy on advanced non-small cell lung cancer.全肿瘤双输入灌注CT在预测多动脉灌注化疗对晚期非小细胞肺癌疗效中的价值
AJR Am J Roentgenol. 2014 Nov;203(5):W497-505. doi: 10.2214/AJR.13.11621.
8
Dynamic volume perfusion computed tomography parameters versus RECIST for the prediction of outcome in lung cancer patients treated with conventional chemotherapy.动态容积灌注 CT 参数与 RECIST 用于预测常规化疗治疗肺癌患者的结局
J Thorac Oncol. 2015 Jan;10(1):164-71. doi: 10.1097/JTO.0000000000000376.
9
Functional imaging in lung cancer.肺癌中的功能成像
Clin Physiol Funct Imaging. 2014 Sep;34(5):340-55. doi: 10.1111/cpf.12104. Epub 2013 Dec 1.
10
Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects.不可切除肺癌的全肿瘤 CT 灌注成像用于监测抗血管生成化疗效果。
Br J Radiol. 2013 Sep;86(1029):20120174. doi: 10.1259/bjr.20120174. Epub 2013 Aug 1.